A neuroendocrine study of 5HT function in depression: evidence for biological mechanisms of endogenous and psychosocial causation
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
To investigate whether depression is a consequence of disturbed function in 5HT systems, neuroendocrine responses to infusions of the 5HT precursor L-tryptophan (LTP) were studied in patients and controls. After an overnight fast and 60 min bed rest, a solution of LTP (10 g/l) was infused intravenously to a dose of 100 mg/kg over 30 min. Circulating growth hormone (GH), prolactin (PRL), cortisol and tryptophan concentrations were followed from 60 min pre-infusion to 60 min post-infusion. GH responses were attenuated in 23 major depressives (DSM-III) compared with 22 controls and were almost absent in endogenous depressives (New-castle criteria). PRL responses were normal in depressives who had lost more than 3 kg body weight but attenuated in those who had not. GH and PRL responses did not correlate with each other. Reduced basal tryptophan concentrations and more rapid tryptophan clearance were observed in the depressives, but there were no correlations with GH or PRL responses. However, basal cortisol concentrations, which were raised in depressives with chronic psychosocial difficulties, were strongly and inversely predictive of PRL responses in depressives and controls. Blunted GH and PRL responses to LTP appear to be distinct abnormalities in depression which may relate to two processes; (1), an endogenous mechanism indicated by reduced GH responses, and (2), an impairment in 5HT systems, indicated by blunted PRL responses and perhaps caused by raised circulating cortisol or reduced tryptophan concentrations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intravenous citalopram (an SSRI) and tryptophan challenge were found reasonably consistently to evoke reduced prolactin and growth hormone responses in depressives compared with controls (Cowen and Charig, 1987;Deakin et al. 1990;Price et al., 1991, Kapitany et al., 1999).”
From Affective Cognition and its Disruption in Mood Disorders (2011) · cites this paper as Deakin et al. 1990
Citations
Cites
"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?
Åsberg, M., Thorén, P., Traskman, L., Bertilsson, L., & Ringberger, V. (1976) · Science · doi:10.1126/science.1246632 · Cited by 682 · cited 1×
“Deakin a global and indirect measure of presynaptic 5HT function in brain and many studies find reduced concentrations in depressives (Sjostrom and Roos 1972; Asberg et al. 1976).”
BackgroundINCREASED SEROTONIN-2 BINDING SITES IN FRONTAL CORTEX OF SUICIDE VICTIMS
Stanley, M., & Mann, J. J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92590-4 · Cited by 529 · cited 1×
“Some, but not all, of these studies report increases in 5HT2 receptor binding ( Stanley and Mann 1983; Crow et al. 1984; Fertier et al. 1986).”
Backgroundde Montigny, C., & Aghajanian, G. K. (1978) · Science · doi:10.1126/science.725608 · Cited by 475
Clinical Trial of the Treatment of Depressive Illness
(1965) · BMJ · doi:10.1136/bmj.1.5439.881 · Cited by 398
CROW, T. (1984) · Neuropharmacology · doi:10.1016/0028-3908(84)90100-x · Cited by 308 · cited 1×
“Some, but not all, of these studies report increases in 5HT2 receptor binding (Stanley and Mann 1983; Crow et al. 1984; Fertier et al. 1986).”
BackgroundBOURNE, H. (1968) · The Lancet · doi:10.1016/s0140-6736(68)92459-8 · Cited by 304
Heninger, G. R. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790150088012 · Cited by 279
Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats
Kennett, G. A., Dickinson, S. L., & Curzon, G. (1985) · Brain Research · doi:10.1016/0006-8993(85)90684-5 · Cited by 253
Cerebrospinal Fluid Amine Metabolites in Affective Illness: The Probenecid Technique
GOODWIN, F. K., POST, R. M., DUNNER, D. L., & GORDON, E. K. (1973) · American Journal of Psychiatry · doi:10.1176/ajp.130.1.73 · Cited by 244
5-Hydroxytryptamine and punishment
TYE, N. C., EVERITT, B. J., & IVERSEN, S. D. (1977) · Nature · doi:10.1038/268741a0 · Cited by 232 · cited 1×
“It has seemed at odds with animal experiments which have implicated 5HT systems in mechanisms of aversion (Wise et al. 1970; Tye et al. 1977; Deakin 1983).”
BackgroundKennett, G. A., Dourish, C. T., & Curzon, G. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90357-8 · Cited by 228 · cited 1×
“This would be compatible with the idea that the ability of chronic antidepressant treatments to enhance 5HT function causes their antidepressant action (De Montigny and Aghajanian 1984; Kennett et al. 1987; Deakin 1989).”
BackgroundCeulemans, D., Hoppenbrouwers, M.-L., Gelders, Y., & Reyntjens, A. (1985) · Pharmacopsychiatry · doi:10.1055/s-2007-1017385 · Cited by 226
Behavioural Pharmacology of 5-HT
Bevan, P., Cools, A. R., & Archer, T. (1990) · International Clinical Psychopharmacology · doi:10.1097/00004850-199004000-00012 · Cited by 194
Roos, B. E., & Sj�str�m, R. (1969) · Pharmacologia Clinica · doi:10.1007/bf00456937 · Cited by 188
Selective Control by Corticosterone of Serotonin Receptor Capacity in Raphe-Hippocampal System
de Kloet, R., Sybesma, H., & Reul, H. M. H. M. (1986) · Neuroendocrinology · doi:10.1159/000124496 · Cited by 180
Decreased plasma tryptophan levels in major depression
Cowen, P. J., Parry-Billings, M., & Newsholme, E. A. (1989) · Journal of Affective Disorders · doi:10.1016/0165-0327(89)90051-7 · Cited by 160 · cited 1×
“While such mechanisms could result in reduced PRL responses in depression, the rise in tryptophan concentrations which followed the direct intravenous infusion of LTP was extremely large and identical in depressives and controls at the time of maximal PRL response (40 min, Fig. 3). Furthermore, in agreement with other…”
ResultNeuroendocrine Responses to Intravenous Tryptophan in Major Depression
Cowen, P. J. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800230038008 · Cited by 129
Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects
Delgado, P. L., Charney, D. S., Price, L. H., Landis, H., & Heninger, G. R. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90114-8 · Cited by 124
Serotonin; From cell biology to pharmacology and therapeutics
(1991) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/0300-9629(91)90452-i · Cited by 120
5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis
Sj�str�m, R., & Roos, B. E. (1972) · European Journal of Clinical Pharmacology · doi:10.1007/bf00561141 · Cited by 116
Biegon, A. R., Rainbow, T. C., & McEwen, B. S. (1985) · Brain Research · doi:10.1016/0006-8993(85)90599-2 · Cited by 111 · cited 1×
“In radioligand binding studies, adrenalectomy increased 5HT1 receptor binding in the rat forebrain and this was reversed by corticosteroid administration (Biegon et al. 1985; De Kloet et al. 1986).”
BackgroundThe effect of intravenous L-tryptophan on prolactin and growth hormone and mood in healthy subjects
Charney, D. S., Heninger, G. R., Reinhard, J. F., Sternberg, D. E., & Hafstead, K. M. (1982) · Psychopharmacology · doi:10.1007/bf00464569 · Cited by 102 · cited 1×
“Charney et al. (1982) reported that infusions of the 5HT precursor L-tryptophan (LTP) caused increases in prolactin (PRL) secretion and that the response was reduced in depressives (Heninger et al. 1984).”
BackgroundHormonal responses to fenfluramine in depressed and control subjects
Mitchell, P. B., & Smythe, G. A. (1990) · Journal of Affective Disorders · doi:10.1016/0165-0327(90)90008-v · Cited by 99 · cited 1×
“These findings suggest that raised cortisol secretion in depression could decrease 5HT1 receptor function and thus attenuate PRL responses to LTP as in this study and to fenfluramine as in others (Lopez-Ibor etal. 1988; Mitchell and Smythe 1989).”
ResultPostsynaptic action by four antidepressive drugs in an animal model of depression
Nagayama, H., Hingtgen, J. N., & Aprison, M. H. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90350-6 · Cited by 97 · cited 1×
“This could be an adaptive response secondary to reduced presynaptic 5HT release in depression, but others have argued that 5HT receptor supersensitivity is the primary event in the pathogenesis of depression (Fuxe et al. 1977; Nagayama et al. 1981 ).”
BackgroundGoodwin, G. M., Fairburn, C. G., & Cowen, P. J. (1987) · Psychological Medicine · doi:10.1017/s0033291700000635 · Cited by 96 · cited 1×
“In agreement with other studies, PRL responses to LTP were considerably increased in depressives who had lost weight compared to those who had not ( Goodwin et al. 1987a, b; Delgado et al. 1989).”
ResultFuxé, K., Ögren, S. O., Agnati, L. F., Gustafsson, J. Å., & JONSSON, G. (1977) · Neuroscience Letters · doi:10.1016/0304-3940(77)90095-7 · Cited by 91 · cited 1×
“This could be an adaptive response secondary to reduced presynaptic 5HT release in depression, but others have argued that 5HT receptor supersensitivity is the primary event in the pathogenesis of depression (Fuxe et al. 1977; Nagayama et al. 1981).”
BackgroundL‐Tryptophan and prolactin release: Evidence for interaction between 5‐HT1 and 5‐HT2 receptors
Charig, E. M., Anderson, I. M., Robinson Sen, J. M., Nutt, D. J., & Cowen, P. J. (1986) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.470010206 · Cited by 82
Postmortem Neurochemical Studies in Depression
Ferrier, I. N., McKeith, I. G., Cross, A. J., Perry, E. K., Candy, J. M., & Perry, R. H. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb27893.x · Cited by 78
Reduced 5-hydroxytryptamine-dependent behaviour in rats following chronic corticosterone treatment
Dickinson, S. L., Kennett, G. A., & Curzon, G. (1985) · Brain Research · doi:10.1016/0006-8993(85)90830-3 · Cited by 78 · cited 1×
“More specifically, components of the rat 5HT syndrome thought to be mediated by 5HT1 receptors were reduced following chronic corticosteroid treatment (Dickinson et al. 1985), including when the behaviours were evoked by the 5HT1 receptor agonist 5-methoxy-N,N-dimethyltryptamine.”
BackgroundGoodwin, G. M. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800230032007 · Cited by 72
WILSON, C. A., & Hunter, A. J. (1985) · Brain Research · doi:10.1016/0006-8993(85)91575-6 · Cited by 63 · cited 1×
“There is evidence of sex differences in 5HT function in animals and evidence for influences of ovarian steroids on 5HT function (e.g. Wilson and Hunter 1985 ).”
BackgroundA Biochemical and Neuroendocrine Study of the Serotonergic System in Depression
Koyama, T., & Meltzer, H. Y. (1986) · Springer eBooks · doi:10.1007/978-3-642-70702-5_19 · Cited by 62
Life Events, Depression and Hypothalamic–Pituitary–Adrenal Axis Function
Dolan, R. J., Galloway, S. P., Fonagy, P., De Souza, F. V. A., & Wakeling, A. (1985) · British Journal of Psychiatry · doi:10.1192/bjp.147.4.429 · Cited by 62 · cited 2×
“More specifically, components of the rat 5HT syndrome thought to be mediated by 5HT1 receptors were reduced following chronic corticosteroid treatment ( Dickinson et al. 1985 ), including when the behaviours were evoked by the 5HT1 receptor agonist 5-methoxy-N,N-dimethyltryptamine.”
BackgroundClomipramine enhances prolactin and growth hormone responses to l-tryptophan
Anderson, I. M., & Cowen, P. J. (1986) · Psychopharmacology · doi:10.1007/bf00175205 · Cited by 61 · cited 1×
“In normal volunteers, pretreatment with the 5HT reuptake blocker clomipramine potentiated PRL and GH responses to LTP, suggesting the involvement of 5HT synapses ( Anderson and Cowen 1986 ).”
Background5-HT and 5-HIAA in cerebrospinal fluid in depression.
Gjerris, A., Sørensen, A., Rafaelsen, O. J., Werdelin, L., Alling, C., & Linnoila, M. (1987) · Journal of Affective Disorders · doi:10.1016/0165-0327(87)90056-5 · Cited by 60
Growth Hormone Response to Clonidine After Recovery in Patients with Endogenous Depression
Mitchell, P. B., Bearn, J., Corn, T. H., & Checkley, S. A. (1988) · The British Journal of Psychiatry · doi:10.1192/bjp.152.1.34 · Cited by 52 · cited 2×
“These findings suggest that raised cortisol secretion in depression could decrease 5HT1 receptor function and thus attenuate PRL responses to LTP as in this study and to fenfluramine as in others (Lopez-Ibor etal. 1988; Mitchell and Smythe 1989 ).”
BackgroundResultJoseph, M. H., Young, S. N., & Curzon, G. (1976) · Biochemical Pharmacology · doi:10.1016/0006-2952(76)90515-3 · Cited by 50 · cited 2×
“Possible explanations of these findings include enhanced tryptophan metabolism by liver pyrrolase and enhanced uptake to the brain or other organs due to reduced concentrations of amino acids which compete for tryptophan transporter (Joseph et al. 1976).”
BackgroundBuprenorphine self-administration by rhesus monkey
Mello, N. K., Bree, M. P., & Mendelson, J. H. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90180-5 · Cited by 49
Theory in psychopharmacology, vol. 1
Mason, S. T. (1983) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(83)90276-6 · Cited by 44
Jj, L.-L., Sáiz, P. A., & Iglesias, L. (1988) · Pharmacopsychiatry · doi:10.1055/s-2007-1014638 · Cited by 43
Møller, S. E., de Beurs, P., Timmerman, L., Tan, B. K., Leijnse-Ybema, H. J., Stuart, M., & Petersen, H. E. H. (1986) · Psychopharmacology · doi:10.1007/bf00310520 · Cited by 42
Nausieda, P. A., Carvey, P. M., & Weiner, W. J. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90035-8 · Cited by 28 · cited 1×
“Chronic corticosteroid treatment reduced rats' behavioural responses to 5HTP ( Nausieda et al. 1982 ) and the small subgroup that reportedly became supersensitive may be an artefact of post-hoc selection.”
BackgroundSerotonin: a possible mediator of behavioral suppression induced by anxiety.
Cd, W., Bd, B., & Stein, L. (1970) · PubMed · Cited by 24
The effect of metergoline on endocrine responses to L-tryptophan
McCance, S., Cowen, P. J., Waller, H., & Smith, A. D. (1987) · Journal of Psychopharmacology · doi:10.1177/026988118700100205 · Cited by 22
Role of 5HT2 Receptors in Anxiety and Depression
Deakin, J. F. W., & Wang, M. (1990) · Springer eBooks · doi:10.1007/978-94-009-1912-9_66 · Cited by 3 · cited 1×
“Gender differences in human 5HT function may explain differences in clinical and psychophysiological responses to drugs with actions on 5HT systems (MRC 1965; Deakin and Wang 1989; Guimaraes et al. 1990).”
BackgroundSelf-citation
Research works printed but not linked: 3
- Cooper SJ, Owen F, Chambers DR, Crow TJ, Johnson J, Poulter M (1986) Post-mortem neurochemical findings in suicide and depression: a study of the serotonergic system and imipramine binding in suicide victims. In: Deakin JFW (ed) The biology of depression. Gaskell, London, pp 53–70
- Deakin JFW (1989) Role of 5HT receptor subtypes in depression and anxiety. In: Archer T, Bevan P, Cools A (eds) Behavioural pharmacology of 5HT. Lawrence Erlbaum, New York (in press)
- Guimaraes FS, Hellewell J, Wang M, Deakin JFW (1990) Sex difference in aversive classical conditioning and responsiveness to anxiolytic drugs in humans. Br J Clin Pharmacol (in press)
Cited by
Discriminative and affective touch: Sensing and feeling.
McGlone, F., Wessberg, J., & Olausson, H. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.001 · Cited by 1,112
“These findings suggest that dynamic tactile allodynia is associated with a reduced CT hedonic touch processing; however, whether CT signaling contributes to the allodynic experience, or reduces the hyperalgesia, remains an open question (Delfini et al., 2013; see also Nagi et al., 2011).”
Background5-HT and mechanisms of defence
Deakin, J. F. W., & Graeff, F. G. (1991) · Journal of Psychopharmacology · doi:10.1177/026988119100500414 · Cited by 1,010
Self-citationRole of 5-HT in stress, anxiety, and depression
Graeff, F. G., Guimarães, F. S., De Andrade, T. G. C. S., & Deakin, J. F. W. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02135-3 · Cited by 984
Self-citationEstrogen–serotonin interactions: implications for affective regulation
Rubinow, D. R., Schmidt, P. J., & Roca, C. A. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00162-0 · Cited by 505
Interferon-alpha–induced changes in tryptophan metabolism
Capuron, L., Neurauter, G., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., Fuchs, D., & Miller, A. H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00173-2 · Cited by 493
Metadata
- Authors
- Deakin, J. F. W., Pennell, I., Upadhyaya, A. J., & Lofthouse, R.
- Affiliations
- Northwick Park Hospital (GB)
- ORCID
- Deakin, J. F. W.
- Venue
- Psychopharmacology
- Published
- 1990-05
- Volume
- 101
- Issue
- 1
- Pages
- 85-92
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W1993015131
- Cited by
- 132
- References
- 45
- Citations by year
- 2020: 1 · 2015: 1 · 2014: 3 · 2013: 2
- FWCI
- 7.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- depression, serotonin, growth hormone, prolactin, cortisol, neuroendocrine response, psychosocial stress, endogenous depression, major depressive disorder
- MeSH terms
- Adolescent, Adult, Depressive Disorder, Female, Humans, Hydrocortisone, Male, Prolactin, Serotonin, Growth Hormone, Tryptophan
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.